Connect with us

Business

Morison gearing to re-shape pharmaceutical industry in SL by 2030

Published

on

Morison’s LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant in Homagama

Sri Lanka’s pharma industry with 1959-roots still producing only 15% of national requirement

Locally manufactured drugs have only 5% market share in private pharma market

Morison to compete with foreign brands with the commencement of commercial manufacturing

by Sanath Nanayakkare

It may be a long journey ahead, but we are going to accomplish it with the support of our science-driven, passionate, young team employed at our pharmaceutical manufacturing plant in Homagama, Dinesh Athapaththu, MD at Morison PLC told the media recently.

He said so while addressing a media roundtable at the LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant operating with minimum human involvement and maximum automation.

“We have embarked on a journey upstream of changing the landscape of the pharma manufacturing industry in Sri Lanka in order to make premium healthcare affordable for everyone,” he said.

“Healthcare is in the news for all the wrong reasons. Some Sri Lankan companies like Morison are trying to take the pharmaceutical industry to the next level after decades of stagnation. However, it is not receiving positive media attention, and therefore, the general public of the country as well as many doctors don’t know what Morison is doing to make this crucial investment work for Sri Lanka.

It has been more than three years since we made this investment and most of our resources still go into product development. Sri Lanka commenced pharmaceutical manufacturing in 1959, but it is still manufacturing just 15% of the national requirement whereas our neigbouring countries are far ahead of us in national supply volumes and export volumes.

“India, Pakistan, Bangladesh and Sri Lanka commenced pharma manufacturing in the 1950s which means pharma manufacturing in these countries got off the ground around the same time in history. In Sri Lanka, that feat was achieved by J.L Morison Son & Jones (Ceylon) PLC. Their facility at Aluth Mawatha, Mutwal became one of the pioneers of generic pharmaceutical manufacturing in Sri Lanka. However, 65 years on, Sri Lanka is still producing only 15% of its national medicine requirement whereas India is self-sufficient plus USD 20 billion worth exports, Bangladesh 95% self-sufficient plus exports worth USD 3 billion, Pakistan 70% self-sufficient plus exports worth USD 5 billion.

Morison enhancing the skill-set of young science and pharma graduates in Sri Lanka

“Sri Lanka’s total pharmaceutical market is estimated at about USD 600 million where 40% of that drugs value is dispensed through government hospitals while 60% is dispensed by private pharmacies. Only 25% of the total 15% locally manufactured pharmaceuticals are dispensed by the government. Most local manufacturers focus on supplying this 25% requirement to the government.

On the other hand, in the private market where doctor-prescribed brands are sold, the locally manufactured products have only a 5% market share, meaning 95% of the products sold in the private market are imported drugs. Having studied this, Morison decided to try and change things around even at this late stage by becoming a manufacturer of branded drugs of international standards in addition to being a bulk generic supplier to the government.”

Dinesh Athapaththu Managing Director at Morison

“Before we built the new plant in Homagama, we went to India and Pakistan to see the pharmaceutical plants there. We realized that we have an issue with the absence of high quality plants in Sri Lanka to go out and promote our products among doctors and private pharmacies. It was evident that we needed to bring high quality pharma manufacturing standards into the country in order to be able to manufacture drugs of the highest quality, safety and efficacy standards such as EU GMP. So we made a bold investment of LKR 4 billion to build this plant. We have been running the plant in compliance with WHO GMP (Good Manufacturing Practice) and EU GMP standards.”

‘Morison decided to take a long term view of this industry and enter the private market, without solely depending on government supplies which could be subject to policy changes from time to time. Therefore, our committed mission now is building a credible pharmaceutical brand which can readily compete with reputed imported pharma brands built on a patient-centric approach.”

“Indian pharma is in a good position today after about 60 -65 years’ of dedication. In Sri Lanka, proper pharmaceutical manufacturing has not significantly evolved. So we have to make necessary changes to transform this industry. For that, primarily we need to take a long term view of sustainable growth and subsequently about the return on investment. Our shareholders are being patient and supportive of our strategy.

We need to attract a lot of qualified young people into the industry to come and work because they will grow with the industry as we are gearing to make a notable impact in the pharmaceutical industry in Sri Lanka. be the best pharma brand in Sri Lanka by 2030, and effectively compete with foreign brands. At our Homagama factory, the average age of our workforce is around 30 years. The beauty of that is; in ten years, the most qualified Sri Lankan pharmaceutical manufacturing personnel will be around 40-years old,” a confident Dinesh said.

J.L. Morison Son & Jones (Ceylon) PLC was acquired by Hemas Holdings PLC in 2013, and today it is re-branded as Morison, retaining a sense of that historical legacy.

Morison’s Homagama manufacturing facility at present manufactures five drugs and has developed about 26 drugs out of which 10- 12 are in NMRA for registration and the rest are to be submitted for registration.

Morison is planning to submit for accreditation for their Homagama facility once it fulfills the complex European procedures, after which Morison’s products will have easier access to lucrative foreign markets, thereby earning much needed foreign currency for Sri Lanka.



Business

ADB approves support to strengthen power sector reforms in Sri Lanka

Published

on

The Asian Development Bank (ADB) has approved a $100 million policy-based loan to further support Sri Lanka in strengthening its power sector. This financing builds on earlier initiatives to establish a more stable and financially sustainable power sector.

This second subprogram of ADB’s Power Sector Reforms and Financial Sustainability Program will accelerate the unbundling of the Ceylon Electricity Board (CEB) into independent successor companies for generation, transmission, system operation, and distribution, as mandated by the Electricity Act of 2024 and its 2025 amendment. The phased approach ensures a structured transition, ensuring progress in reform actions and prioritizing financial sustainability.

“Sri Lanka has made important progress in stabilizing its economy and strengthening its fiscal position. A well-functioning power sector is vital for the country’s continued recovery and sustainable growth,” said ADB Country Director for Sri Lanka Takafumi Kadono. “ADB is committed to supporting Sri Lanka’s long-term development and advancing key reforms in the power sector. This initiative will enhance power sector governance, foster private sector participation, and accelerate renewable energy development to drive sustainable recovery, resilience, and inclusive growth.”

To improve financial sustainability, the program will help implement cost-reflective tariffs and a comprehensive debt restructuring plan for the CEB. It will support the new independent successor companies in transparent allocation of existing debts. This will continue to strengthen their financial viability, enhance creditworthiness, and enable these companies to operate on a more sustainable footing.

The program also aims to strengthen renewable energy development and private sector participation by enhancing transparency and supporting power sector entities that are financially sustainable. It will enable competitive procurement for large-scale renewable energy projects and identified priority generation schemes, while upholding strong environmental standards.

Promoting gender equality and social inclusion is integral to the program. Energy sector agencies have implemented annual women’s leadership programs, adopted inclusive policies, and launched feedback mechanisms to ensure equitable participation of female consumers and entrepreneurs. The program includes targeted support for vulnerable groups, such as maintaining lifeline tariffs and implementing measures to soften the impact of tariff adjustments and sector reforms.

ADB will provide an additional $2.5 million technical assistance grant from its Technical Assistance Special Fund to support program implementation, build the capacity of successor companies, and help develop their business plans and power system development plans.

Continue Reading

Business

Union Assurance becomes first insurer to earn the YouTube Silver Play Button

Published

on

Union Assurance, Sri Lanka’s longest-standing private Life Insurer, has achieved a milestone in its digitalisation journey by being awarded the YouTube Silver Play Button, recognising the Company for surpassing 100,000 subscribers on its official channel. This achievement marks a first in Sri Lanka’s Insurance industry, across both Life and General Insurance, and underscores Union Assurance’s pioneering role in digital engagement.

This accomplishment reflects the Company’s unwavering commitment to making Life Insurance accessible, simplified, and engaging for all Sri Lankans. Through innovative content strategies, Union Assurance has successfully transformed complex Insurance concepts into relatable, informative, and inspiring narratives that empower individuals to protect what matters most; health, wealth, family, and future.

Receiving the Silver Play Button is more than a symbolic accolade; it is a testament to the strength and credibility of Union Assurance’s digital presence. In an era where trust and transparency define brand loyalty, this recognition validates the company’s ability to create content that resonates deeply with a growing audience. It enhances the brand’s authority, reinforces its visibility across digital platforms, and further solidifies Union Assurance as a leader in customer engagement.

Celebrating this achievement, Mahen Gunarathna, the Chief Marketing Officer at Union Assurance stated: “This milestone is a testament to the trust and engagement of our audience and reflects our dedication to innovation, transparency, and customer-centric communication.

Continue Reading

Business

LOLC Finance Factoring powers business growth

Published

on

Deepamalie Abhayawardane, Head of Factoring at LOLC Finance PLC

LOLC Finance PLC, the largest non-banking financial institution in Sri Lanka, brings to light the significant role of its Factoring Business Unit in providing indispensable financial solutions to businesses across the country. With a robust network of over 200 branches, LOLC Finance Factoring offers distinctive support to enterprises, ranging from small-scale entrepreneurs to corporate giants.

In light of the recent economic challenges, LOLC Finance Factoring emerged as a lifeline for most businesses, ensuring continuous liquidity to navigate through turbulent times. By facilitating seamless transactions through online platforms and expediting payments, the company played a pivotal role in sustaining essential services, including supermarkets and pharmaceuticals.

Deepamalie Abhaywardane, Head of Factoring at LOLC Finance PLC, emphasized the increasing relevance of factoring in today’s economy. “As economic conditions become more stringent, factoring emerges as the most sought-after financial product for businesses across various sectors. It offers a win-win solution by providing upfront cash up to 85% of the credit sale to suppliers while allowing end-users/buyers better settlement period.”

One of the standout features of LOLC Finance Factoring is its hassle-free application process. Unlike traditional bank loans that require collateral, LOLC Factoring extends credit facilities without such obligations. Furthermore, LOLC Finance Factoring relieves business entities of the burden of receivable management and debt collection. Through nominal service fees, businesses can outsource these tasks, allowing them to focus on core operations while ensuring efficient cash flow management.

For businesses seeking Shariah-compliant factoring solutions, LOLC Al-Falaah’s Wakalah Future-Cash Today offers an efficient and participatory financing model that meets both financial needs and ethical principles. Understanding the diverse challenges faced by businesses, LOLC Finance Factoring deliver tailored solutions that enhance cash flow, reduce credit risk, and support sustainable growth. Working together with LOLC Al-Falaah ensures access to a transparent, well-structured receivable management solution strengthened by the credibility and trust of Sri Lanka’s largest NBFI, LOLC Finance.

The clientele of LOLC Finance Factoring spans into various industries, including manufacturing, trading, transportation, healthcare, textiles, plantations, and other services, all contributing significantly to Sri Lanka’s economic growth. By empowering businesses with accessible and convenient working capital solutions, LOLC Finance’s Factoring arm plays a vital role in fostering economic development and prosperity of the country.

In the upcoming quarter, LOLC Finance Factoring remains committed to delivering innovative financial solutions tailored to meet the evolving needs of businesses. As Sri Lanka’s economic landscape continues to develop, LOLC Finance Factoring stands ready to support enterprises on their journey towards growth and success.

Continue Reading

Trending